Access to Healthcare
Boehringer Ingelheim is a global and diverse group of companies and people all driven by the desire to serve mankind by improving human and animal health. We are proud of our long history of philanthropy and social responsibility. Family-owned since our founding in 1885, we feel a special responsibility for our communities and respect for our resources. As we continue to develop breakthrough therapies and healthcare solutions in areas of unmet medical need, access is core to our business and values. We aspire to the sustainable delivery of More Health to humans, animals and communities around the world by building unique initiatives, both commercial and philanthropic, based on partnerships and local empowerment.
-
Access to healthcare
Kuza Afya and Tiba Yako making significant contributions to hypertension and diabetes care in Kenya
-
Access to healthcare
The 'LastMile' initiative aims to make a significant impact on the smallholder animal health market in Africa where it is delivered by Boehringer Ingelheim, a leading player in the global animal health industry.
-
Access to healthcare
Learn more about our healthcare pilot program in Kenya, which reflects all elements of our three-pillar strategic framework
-
DOWNLOAD PDF (360.88 KB)
Boehringer Ingelheim aspires to the sustainable delivery of more health to humans, animals and communities around the world by building unique initiatives and partnerships.
-
Access to healthcare
Boehringer Ingelheim aspires to be a leader in ensuring improved access in all low- and middle-income countries by delivering more health to humans, animals and communities around the world. Read more about our holistic approach, based on partnerships and local empowerment.
-
Access to healthcare
Dr Antonio Ruffolo, Head of Access to Healthcare and Global Health Policy, speaks about the current ranking of Boehringer Ingelheim